人類預防性疫苗市場：按疫苗類型、技術平台、應用和地區分類。

Prophylactic Human Vaccine Market, By Vaccine Type, By Technology Platform, By Application, By Geography

出版日期: 2026年04月28日 | 出版商:

Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2026年人類預防性疫苗市場規模估計為779億美元，預計2033年將達到1,153億美元。預計2026年至2033年，該市場將以7.0%的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	779億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	7.00%	2033年市場規模預測：	1153億美元

全球預防性人用疫苗市場涵蓋四價、二價、單價及類似類型的疫苗產品。這些疫苗用於兒童、成人和老年人的免疫接種，並被各類終端用戶廣泛採用。隨著各組織機構日益重視疫苗的性能、效率和成本效益，這些領域的疫苗應用也穩定成長。

市場動態：

來自主要終端用戶產業的需求不斷成長、對提高效率和可靠性的需求以及持續的產品創新，預計將是推動全球人類預防性疫苗市場成長的主要因素。兒童和成人免疫接種的日益普及進一步加速了這一成長勢頭。

例如，市場參與者正在部署專為兒童免疫接種應用場景設計的先進解決方案。此外，預計在預測期內，持續的技術進步和策略投資將為市場參與者創造新的成長機會。

本研究的主要特點：

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據公司概況、產品系列、主要亮點、財務表現和策略等參數，介紹了全球人類預防性疫苗市場主要公司的概況。
本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、產品類型升級、市場擴張和行銷策略做出明智的決策。
這份「全球人類預防性疫苗市場」報告的目標受群眾外包括產業內的各類相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過分析全球人類預防性疫苗市場中使用的各種策略矩陣來簡化決策過程。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 比荷盧經濟聯盟
- 丹麥
- 挪威
- 瑞典
- 其他歐洲國家
亞太地區
- 中國
- 台灣
- 印度
- 日本
- 印尼
- 馬來西亞
- 菲律賓
- 新加坡
- 澳洲
- 韓國
- 其他亞太國家
中東和非洲
巴林
科威特
阿曼
卡達
沙烏地阿拉伯
UAE
以色列
南非
北非
中非
其他中東國家

第1章競爭情勢

Sanofi Pasteur
Pfizer Inc.
GlaxoSmithKline plc
Merck & Co., Inc.
Bharat Biotech International Limited
Serum Institute of India Pvt. Ltd.
Johnson & Johnson
Novavax, Inc.
Sinovac Biotech Ltd.
BioNTech SE
AstraZeneca Plc

第2章

調查方法
關於本公司

簡介目錄

Product Code: CMI2261

Prophylactic Human Vaccine Market is estimated to be valued at USD 77.90 billion in 2026 and is expected to reach USD 115.3 billion by 2033, growing at a compound annual growth rate (CAGR) of 7.0% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 77.90 billion
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	7.00%	2033 Value Projection:	USD 115.3 billion

The global prophylactic human vaccine market includes offerings that span Quadrivalent, Bivalent, and Monovalent, and similar vaccine type categories. These are applied across Pediatric Immunization, Adult Vaccination, and Geriatric Vaccination and adopted by diverse end users. As organizations increasingly prioritize performance, efficiency, and cost-effectiveness, adoption across these segments continues to grow steadily.

Market Dynamics:

Increasing demand from major end-use sectors, the need for improved efficiency and reliability, and ongoing product innovation are major factors expected to drive growth of the global prophylactic human vaccine market. Broader adoption across Pediatric Immunization, and Adult Vaccination is reinforcing this momentum.

For instance, market players are introducing advanced solutions designed for Pediatric Immunization use cases. Moreover, continued technological advancement and strategic investment are expected to create new growth opportunities for market players over the forecast period.

Key features of the study:

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global prophylactic human vaccine market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Sanofi Pasteur; Pfizer Inc.; GlaxoSmithKline plc; Merck & Co., Inc.; Bharat Biotech International Limited; Serum Institute of India Pvt. Ltd.; Johnson & Johnson; Novavax, and Inc.; Sinovac Biotech Ltd.; BioNTech SE; AstraZeneca Plc, among others.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global prophylactic human vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global prophylactic human vaccine market.

Detailed Segmentation:

Global Prophylactic Human Vaccine Market, By Vaccine Type (Revenue, USD Bn, 2021 - 2033)
Quadrivalent
Bivalent
Monovalent
Pentavalent
Others
Global Prophylactic Human Vaccine Market, By Technology Platform (Revenue, USD Bn, 2021 - 2033)
Live Attenuated
Inactivated
Recombinant
mRNA-based
Others
Global Prophylactic Human Vaccine Market, By Application (Revenue, USD Bn, 2021 - 2033)
Pediatric Immunization
Adult Vaccination
Geriatric Vaccination
Others
Regional Insights (Revenue, USD Bn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Company Profiles:
Sanofi Pasteur; Pfizer Inc.; GlaxoSmithKline plc; Merck & Co.*
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
Inc.; Bharat Biotech International Limited; Serum Institute of India Pvt. Ltd.; Johnson & Johnson; Novavax
Inc.; Sinovac Biotech Ltd.; BioNTech SE; AstraZeneca Plc

"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Preview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Vaccine Type
- Market Snapshot, By Technology Platform
- Market Snapshot, By Application
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Recent Product Launches
Epidemiology
Merger, Acquisition, and Collaboration
Regulatory Scenario
Key Developments
PEST Analysis
Partnership Scenario
Brand and Pricing Analysis
Distributors Landscape
Porters Analysis
Technological Advancements
Key Developments
Market Trend
Future Prospective
Top Market Players by Revenue

4. Prophylactic Human Vaccine Market By Vaccine Type, 2026-2033, (US$ Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Quadrivalent
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
Bivalent
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
Monovalent
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
Pentavalent
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)

5. Prophylactic Human Vaccine Market By Technology Platform, 2026 - 2033, (US$ Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Live Attenuated
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
Inactivated
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
Recombinant
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
mRNA-based
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)

6. Prophylactic Human Vaccine Market By Application, 2026 - 2033, (US$ Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Pediatric Immunization
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
Adult Vaccination
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
Geriatric Vaccination
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)

7. Prophylactic Human Vaccine Market By Region, 2026 - 2033, (US$ Billion)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022-2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, en2026-2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Technology Platform, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Technology Platform, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Technology Platform, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Benelux
  - Denmark
  - Norway
  - Sweden
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Technology Platform, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)
  - China
  - Taiwan
  - India
  - Japan
  - Indonesia
  - Malaysia
  - Philippines
  - Singapore
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Technology Platform, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)
Bahrain
Kuwait
Oman
Qatar
Saudi Arabia
UAE
Israel
South Africa
North Africa
Central Africa
Rest of the Middle East

1. Competitive Landscape

Sanofi Pasteur
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
GlaxoSmithKline plc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Merck & Co., Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Bharat Biotech International Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Serum Institute of India Pvt. Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Novavax, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Sinovac Biotech Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
BioNTech SE
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
AstraZeneca Plc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies